Cardiovascular News Issue 42 – August 2016

190

Highlights: Study indicates signal for valve degeneration in TAVI patients by eight years; Absorb now available in the USA following FDA approval; Profile of Philip Urban; Olaf Wendler & Miriam Silaschi on what is required of TAVI to become the new gold standard?